Effect of Lymphopenia on Tumor Response and Clinical Outcomes Following Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer

BACKGROUND: Prior studies suggest lymphopenia, systemic immune-inflammatory index, and tumor response all impact clinical outcomes in Stage III NSCLC. We hypothesized that tumor response after CRT would be associated with hematologic metrics and might predict clinical outcomes. MATERIALS AND METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Deck, Jared, Hartley, Marissa, Akhter, Mohammad, Wang, Dongliang, Bogart, Jeffrey A, Mix, Michael D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204762/
https://www.ncbi.nlm.nih.gov/pubmed/37228390
http://dx.doi.org/10.2147/LCTT.S386344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204762/
https://www.ncbi.nlm.nih.gov/pubmed/37228390
http://dx.doi.org/10.2147/LCTT.S386344

Ejemplares similares